BIOA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.5M
-11.6%
2.8M
-9.9%
3.1M
+49.9%
2.1M
-14.8%
2.4M
Cost of Revenue
0
0
0
0
0
Gross Profit
2.5M
-11.6%
2.8M
-9.9%
3.1M
+49.9%
2.1M
-14.8%
2.4M
Operating Expenses
31.8M
+12.9%
28.1M
-10.6%
31.5M
+25.0%
25.2M
-7.3%
27.2M
R&D
24.4M
+19.4%
20.4M
-16.7%
24.5M
+32.3%
18.5M
-6.7%
19.8M
SG&A
7.4M
-4.1%
7.7M
+10.5%
7.0M
+4.8%
6.7M
-9.0%
7.3M
Operating Income
-29333000
-15.6%
-25375000
+10.7%
-28423000
-22.8%
-23140000
+6.6%
-24771000
EBITDA
-29263000
-15.6%
-25312000
+10.7%
-28354000
-22.8%
-23091000
+6.6%
-24713000
Net Income
-26097000
-17.3%
-22253000
+14.2%
-25943000
-28.6%
-20171000
+6.5%
-21563000
EPS (Basic)
$-0.58
-11.5%
$-0.52
+27.8%
$-0.72
-28.6%
$-0.56
+6.7%
$-0.60
EPS (Diluted)
$-0.58
-11.5%
$-0.52
+27.8%
$-0.72
-28.6%
$-0.56
+6.7%
$-0.60
Shares (Diluted)
44.8M
+5.6%
42.5M
+17.4%
36.2M
+0.9%
35.9M
+0.0%
35.9M
BioAge Labs (BIOA) โ€” Financials